P21 is a nootropic peptide derived from the larger peptide cerebrolysin, which has been used in neurodegenerative treatments. P21 specifically targets the brain’s cognitive functions, enhancing memory, learning capacity, and neuroprotection. It has shown promise in research aimed at treating neurodegenerative diseases such as Alzheimer’s and other forms of dementia, and it may also benefit individuals looking to improve cognitive function, focus, and memory retention.
P21 was developed through the study of cerebrolysin, a neuropeptide mixture known for its neuroprotective and neurotrophic properties. Researchers isolated P21 as one of cerebrolysin’s key active components, focusing on its ability to support neuronal health, particularly in the hippocampus, which plays a crucial role in memory formation. Early studies on P21 explored its potential to improve cognitive function and slow the progression of neurodegenerative conditions.
SKU: MAF/P21/10/SV/KIT
